Annual Working Capital
$315.37 M
+$30.57 M+10.74%
December 31, 2023
Summary
- As of February 7, 2025, FOLD annual working capital is $315.37 million, with the most recent change of +$30.57 million (+10.74%) on December 31, 2023.
- During the last 3 years, FOLD annual working capital has fallen by -$134.42 million (-29.89%).
- FOLD annual working capital is now -32.17% below its all-time high of $464.97 million, reached on December 31, 2018.
Performance
FOLD Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$340.34 M
+$46.70 M+15.90%
September 30, 2024
Summary
- As of February 7, 2025, FOLD quarterly working capital is $340.34 million, with the most recent change of +$46.70 million (+15.90%) on September 30, 2024.
- Over the past year, FOLD quarterly working capital has increased by +$46.53 million (+15.84%).
- FOLD quarterly working capital is now -37.59% below its all-time high of $545.33 million, reached on June 30, 2019.
Performance
FOLD Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
FOLD Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.7% | +15.8% |
| 3 y3 years | -29.9% | +15.8% |
| 5 y5 years | -32.2% | +15.8% |
FOLD Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.1% | +10.7% | -24.5% | +30.2% |
| 5 y | 5-year | -30.1% | +10.7% | -35.7% | +30.2% |
| alltime | all time | -32.2% | +1316.3% | -37.6% | +1428.5% |
Amicus Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $340.34 M(+15.9%) |
| Jun 2024 | - | $293.63 M(+1.6%) |
| Mar 2024 | - | $289.14 M(-8.3%) |
| Dec 2023 | $315.37 M(+10.7%) | $315.37 M(+7.3%) |
| Sep 2023 | - | $293.80 M(+7.4%) |
| Jun 2023 | - | $273.59 M(+4.7%) |
| Mar 2023 | - | $261.31 M(-8.2%) |
| Dec 2022 | $284.80 M(-36.8%) | $284.80 M(-3.1%) |
| Sep 2022 | - | $293.89 M(-11.7%) |
| Jun 2022 | - | $333.02 M(-14.4%) |
| Mar 2022 | - | $389.20 M(-13.7%) |
| Dec 2021 | $450.86 M(+0.2%) | $450.86 M(-14.8%) |
| Sep 2021 | - | $529.44 M(+43.7%) |
| Jun 2021 | - | $368.51 M(-8.6%) |
| Mar 2021 | - | $403.24 M(-10.4%) |
| Dec 2020 | $449.79 M(+15.0%) | $449.79 M(-5.0%) |
| Sep 2020 | - | $473.55 M(+71.8%) |
| Jun 2020 | - | $275.58 M(-12.9%) |
| Mar 2020 | - | $316.24 M(-19.2%) |
| Dec 2019 | $391.26 M(-15.9%) | $391.26 M(-19.1%) |
| Sep 2019 | - | $483.58 M(-11.3%) |
| Jun 2019 | - | $545.33 M(+30.7%) |
| Mar 2019 | - | $417.18 M(-10.3%) |
| Dec 2018 | $464.97 M(+44.4%) | $464.97 M(-13.1%) |
| Sep 2018 | - | $535.15 M(+2.3%) |
| Jun 2018 | - | $523.27 M(+15.9%) |
| Mar 2018 | - | $451.33 M(+40.2%) |
| Dec 2017 | $321.93 M(+40.5%) | $321.93 M(-11.3%) |
| Sep 2017 | - | $362.85 M(+158.6%) |
| Jun 2017 | - | $140.31 M(-24.8%) |
| Mar 2017 | - | $186.61 M(-18.5%) |
| Dec 2016 | $229.10 M(+60.2%) | $229.10 M(+68.3%) |
| Sep 2016 | - | $136.10 M(-0.8%) |
| Jun 2016 | - | $137.22 M(+31.8%) |
| Mar 2016 | - | $104.09 M(-27.2%) |
| Dec 2015 | $142.99 M | $142.99 M(-30.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $204.19 M(-41.3%) |
| Jun 2015 | - | $348.10 M(+167.3%) |
| Mar 2015 | - | $130.23 M(-3.1%) |
| Dec 2014 | $134.39 M(+72.7%) | $134.39 M(+83.1%) |
| Sep 2014 | - | $73.41 M(+7.6%) |
| Jun 2014 | - | $68.25 M(+6.5%) |
| Mar 2014 | - | $64.08 M(-17.6%) |
| Dec 2013 | $77.82 M(-18.4%) | $77.82 M(+39.7%) |
| Sep 2013 | - | $55.71 M(-17.1%) |
| Jun 2013 | - | $67.21 M(-15.8%) |
| Mar 2013 | - | $79.82 M(-16.3%) |
| Dec 2012 | $95.37 M(+101.2%) | $95.37 M(-7.0%) |
| Sep 2012 | - | $102.55 M(+16.7%) |
| Jun 2012 | - | $87.86 M(-9.9%) |
| Mar 2012 | - | $97.52 M(+105.8%) |
| Dec 2011 | $47.39 M(-49.3%) | $47.39 M(-18.0%) |
| Sep 2011 | - | $57.77 M(-18.9%) |
| Jun 2011 | - | $71.22 M(-14.6%) |
| Mar 2011 | - | $83.41 M(-10.8%) |
| Dec 2010 | $93.46 M(+34.9%) | $93.46 M(+78.6%) |
| Sep 2010 | - | $52.33 M(-18.2%) |
| Jun 2010 | - | $64.00 M(-14.8%) |
| Mar 2010 | - | $75.10 M(+8.4%) |
| Dec 2009 | $69.29 M(-37.1%) | $69.29 M(-9.4%) |
| Sep 2009 | - | $76.49 M(-12.9%) |
| Jun 2009 | - | $87.85 M(-10.8%) |
| Mar 2009 | - | $98.48 M(-10.6%) |
| Dec 2008 | $110.21 M(-25.2%) | $110.21 M(-10.6%) |
| Sep 2008 | - | $123.31 M(-6.1%) |
| Jun 2008 | - | $131.32 M(-6.7%) |
| Mar 2008 | - | $140.82 M(-4.4%) |
| Dec 2007 | $147.25 M(+228.6%) | $147.25 M(+32.6%) |
| Sep 2007 | - | $111.08 M(-7.6%) |
| Jun 2007 | - | $120.19 M(+101.9%) |
| Mar 2007 | - | $59.53 M(+32.8%) |
| Dec 2006 | $44.81 M(+101.3%) | $44.81 M(+101.3%) |
| Dec 2005 | $22.27 M | $22.27 M |
FAQ
- What is Amicus Therapeutics annual working capital?
- What is the all time high annual working capital for Amicus Therapeutics?
- What is Amicus Therapeutics annual working capital year-on-year change?
- What is Amicus Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly working capital year-on-year change?
What is Amicus Therapeutics annual working capital?
The current annual working capital of FOLD is $315.37 M
What is the all time high annual working capital for Amicus Therapeutics?
Amicus Therapeutics all-time high annual working capital is $464.97 M
What is Amicus Therapeutics annual working capital year-on-year change?
Over the past year, FOLD annual working capital has changed by +$30.57 M (+10.74%)
What is Amicus Therapeutics quarterly working capital?
The current quarterly working capital of FOLD is $340.34 M
What is the all time high quarterly working capital for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly working capital is $545.33 M
What is Amicus Therapeutics quarterly working capital year-on-year change?
Over the past year, FOLD quarterly working capital has changed by +$46.53 M (+15.84%)